Skip to content
Recall Observatory FDA recall evidence

Drug product

UROLET MB URINARY ANTISEPTIC, ANTISPASMODIC Tablets, Each tablet contains: Methenamine 81.6 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue, 10.8 mg; Hyoscyamine Sulfate, 0.12 mg, (a) 30 count (NDC 35573-302-30) and (b) 100 count bottles (NDC 35573-302-10), Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS

D-0156-2017

October 24, 2016

Class II

Product summary

Firm
Burel Pharmaceuticals Inc
Event
Event 75566
Status
Terminated
Classification
Class II
Quantity
11,539 bottles
Official record key
drug-enforcement:D-0156-2017

Official wording

Reason: CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures

Code information: (a) LOT # 28981501, EXP 8/17, NDC 35573-302-30; (b) LOT # 28981501, EXP 8/17, LOT # 28981601, EXP 4/18, NDC 35573-302-10

Distribution pattern: Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations; deficiencies